Published in Psychopharmacologia on January 01, 1967
[Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome]. Presse Med (1969) 1.77
Qualitative analysis of unilateral spatial neglect in relation to laterality of cerebral lesions. J Neurol Neurosurg Psychiatry (1972) 1.57
Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med (1989) 1.33
Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol (1989) 1.29
Pick's disease. Histological and clinical correlations. Eur Neurol (1974) 1.27
Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. Brain Res (1967) 1.14
[Oculo-facio-cervical dystonia (Steele-Richardson-Olszewski progressive supranuclear paralysis). Ophthalmic pseudo-paralysis, visuo-spatial disorders, pseudo-dementia and neuronal changes]. Rev Neurol (Paris) (1970) 1.10
The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Clin Pharmacol Ther (1971) 1.06
A pedigree possible evidence for the metabolic interference hypothesis. Am J Hum Genet (1981) 1.03
[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?]. Presse Med (1971) 1.00
[Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. Presse Med (1969) 0.98
[Generalized Alzheimer's neurofibrillary lesions without senile plaques. (Presentation of one anatomo-clinical case)]. Schweiz Arch Neurol Neurochir Psychiatr (1967) 0.93
Drug-induced changes of extracerebral dopa metabolism in man. Arch Neurol (1969) 0.93
Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain. Experientia (1968) 0.92
gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther (1982) 0.88
The common pathophysiology of monaminergic psychoses: a new hypothesis. Neuropsychobiology (1975) 0.87
On the origin of homovanillic acid in the cerebrospinal fluid. Experientia (1966) 0.87
EEG sleep studies of insomniacs under flunitrazepam treatment. Int Pharmacopsychiatry (1975) 0.86
[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II]. Rev Neurol (Paris) (1970) 0.86
The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand (1987) 0.86
Inherited congenital adrenal hyperplasia in the rabbit: absent cholesterol side-chain cleavage cytochrome P450 gene expression. Endocrinology (1992) 0.86
[Recent aspects of the study of sleep in humans]. Schweiz Arch Neurol Neurochir Psychiatr (1965) 0.85
Delta sleep-inducing peptide in the rat brain: an immunohistological microscopic study. Neuropsychobiology (1983) 0.82
Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas. Neuropsychobiology (1986) 0.81
[Familial incidence of Alzheimer's cortical neurofibrillar changes]. Psychiatr Neurol (Basel) (1965) 0.81
[The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat]. Experientia (1970) 0.81
Pseudophakic ametropia managed with a phakic posterior chamber intraocular lens. J Cataract Refract Surg (2001) 0.81
[Plasma MHPG, peripheral noradrenergic marker and hormonal plasma levels of cortisol-T3-T4-TSH in depressive syndromes]. Encephale (1991) 0.81
Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. Biochem Pharmacol (1971) 0.81
[The future of suicidal patients admitted to a general hospital. Comparative study of 2 methods of prevention recurrence and of suicides]. Soz Praventivmed (1979) 0.81
Brain capillaries as a source of homovanillic acid in cerebrospinal fluid. Brain Res (1971) 0.81
[Automatic analysis of polygraphic sleep recordings]. Electroencephalogr Clin Neurophysiol (1971) 0.80
[Plasma levels and membrane transports in red blood cell of tyrosine and tryptophane in depression. Evaluation at baseline and recovery]. Encephale (1991) 0.80
Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics. Int Clin Psychopharmacol (1989) 0.80
[Urinary excretion of 5-hydroxyindoleacetic acid, vanillomandelic acid and xanthurenic acid in 18 Mongoloids]. Pathol Biol (1966) 0.80
Monozygotic twin brothers with age-related macular degeneration. Ophthalmologica (1992) 0.80
Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J Pharm Pharmacol (1972) 0.80
[Study of H and T reflexes in Parkinsonism. Modification of these reflexes by L-Dopa]. Encephale (1971) 0.79
[Progabide treatment of a case of the syndrome of painful legs and moving toes]. Rev Neurol (Paris) (1985) 0.79
[Degeneration of an anterior segment of the corpus callosum in a chronic alcoholic patient]. Rev Otoneuroophtalmol (1971) 0.79
Principles of automatic analysis of sleep records with a hybrid system. Comput Biomed Res (1973) 0.79
Involvement of sulfhydryl groups in the transport of L-tyrosine and L-tryptophan across the human red cell membrane in vitro. Neuropsychobiology (1989) 0.78
[Effect of large doses of L-DOPA on the cerebral electrical activity of rabbits (interaction with the metabolism of 5-HT)]. Arch Int Pharmacodyn Ther (1973) 0.78
[The capillary barrier for dopa in brain and different organs]. Psychopharmacologia (1969) 0.78
Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry. Experientia (1974) 0.78
Passage into the rat brain of dopa and dopamine injected into the lateral ventricle. Br J Pharmacol (1971) 0.78
Inositol monophosphate esterase inhibition by lithium in normal human studies using neuroendocrine tests. Part I. PRL and TSH responses to TRH. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.78
[Pick's disease and zinc metabolism]. Rev Neurol (Paris) (1977) 0.78
Aspects of cognitive activity in schizophrenia. Psychol Med (1980) 0.77
[Senile plaques, neuro-fibrillar degeneration and other associated cerebral lesions (morphology and pathogenetic theory]. Schweiz Arch Neurol Neurochir Psychiatr (1979) 0.77
The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther (1975) 0.77
[Modification of the cerebral electrical activity of the rabbit by micro-injections of monoamine precursors into bulbar and pontine sleep-producing structures]. Electroencephalogr Clin Neurophysiol (1966) 0.77
Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res (1993) 0.77
[Changes occurring in psychotherapy measured by the Osgood semantic differential--methodologic elaboration]. Schweiz Arch Neurol Psychiatr (1986) 0.77
Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables. Acta Psychiatr Scand (1990) 0.77
Platelet [3H]-imipramine binding according to DSM-III subtypes of depression. Neuropsychobiology (1989) 0.77
Beta-adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol Psychiatry (1991) 0.77
[Calcium EDTA treatment of Pick's disease]. Nouv Presse Med (1978) 0.77
[Erythrocyte membrane transport and plasma levels of tyrosine and tryptophan in depression]. Encephale (1988) 0.77
[The eye as an art form: the ocular prosthesis]. Klin Monbl Augenheilkd (1992) 0.76
[Probable interaction of psyllium and lithium]. Therapie (1990) 0.76
Plasma MHPG and age at onset in depressed patients. Psychiatry Res (1989) 0.76
Platelet membrane alpha 2-adrenergic receptors in depression. Psychiatry Res (1992) 0.76
[The morphology of substance P in the human brain as determined by an immuno-histo-fluorescence study]. Schweiz Arch Neurol Neurochir Psychiatr (1980) 0.76
The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients. Acta Psychiatr Scand (1989) 0.76
[Changes in the kinetics of erythrocyte membrane transport of tryptophan in depression]. Encephale (1989) 0.76
Experimental models in human melanoma research: a logical perspective. Semin Oncol (1988) 0.76
[Subjective perception of the effect of neuroleptics by outpatient schizophrenic patients: a cross-sectional study]. Encephale (1999) 0.76
Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology (1992) 0.76
[On several aspects of difficulties in dressing in senile degenerative dementia or diffuse vascular lesions]. Ann Med Psychol (Paris) (1967) 0.76
A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement. Neuropsychobiology (1990) 0.76
[Methodologic attempt at analysis of the sleep cycle]. Encephale (1966) 0.75
[Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes]. Encephale (1972) 0.75
Role of glutamate and zinc in the hippocampal lesions of Pick's disease. Adv Biochem Psychopharmacol (1981) 0.75
[Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase]. Arch Int Pharmacodyn Ther (1969) 0.75
Evaluation of psychotherapies and Osgood's Semantic Differential. A tentative approach. Psychother Psychosom (1980) 0.75
Involvement of 5-hydroxytryptamine in the cortical synchronization induced by L-DOPA in the rabbit. Brain Res (1974) 0.75
[Effect of some tranquilizers on motility during sleep]. Psychopharmacologia (1965) 0.75
[Automatic analysis of sleep by a hybrid system: new results]. Electroencephalogr Clin Neurophysiol (1972) 0.75
Does splenectomy decrease the incidence of hyperacute rejection? Surg Forum (1971) 0.75
[Acquisition of a sensory-motor schema by subjects with fixation amnesia. Memory in the strict sense--memory in the broad sense, according to Piaget]. Ann Med Psychol (Paris) (1977) 0.75
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)]. Neurol Neurocir Psiquiatr (1969) 0.75
[Nature of operative deficiency in aged patients with degenerative dementia: conservation of physical quantities causality and transitivity tests]. Encephale (1972) 0.75
[Visual perceptual activities in senile degenerative dementia]. Rev Otoneuroophtalmol (1973) 0.75
[Uptake of tryptophan and tyrosine in some cases of manic depressive psychosis and schizophrenia (author's transl)]. Neuropsychobiology (1978) 0.75
[Elementary logic and semantic fields in aphasia]. Rev Neurol (Paris) (1976) 0.75
[Eating behavior in degenerative dementias or mixed dementias with a predominance of degeneration in old age]. Ann Med Psychol (Paris) (1976) 0.75
[Comparison of the sleep-inducing effect of Ro 5-4200 and nitrazepam]. Psychopharmacologia (1972) 0.75
[Aspects of cognitive activities in the schizophrenic]. Ann Med Psychol (Paris) (1975) 0.75
[Sleep in the young adult studied through automatic analysis of recordings]. Electroencephalogr Clin Neurophysiol (1976) 0.75
[Effects of static stretching of the soleus muscle on Hoffman's reflex in parkinsonism; modification of these effects with L-Dopa]. Rev Neurol (Paris) (1971) 0.75
[Modalities of treatment of Parkinsonian syndrome with L-dopa]. Int J Neurol (1972) 0.75
[Study of aminoaciduria in a group of mental defectives]. Rev Med Suisse Romande (1966) 0.75
[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor]. Rev Eur Etud Clin Biol (1972) 0.75
[Correlations between electroencephalographic changes and anatomo-histologic lesions in dementia]. Encephale (1970) 0.75
[Automatic analysis of polyraph recordings of sleep]. Experientia (1971) 0.75
[Attempted localization of monoamines in human hypothalamus]. Pathol Biol (Paris) (1969) 0.75
Location of light chain tyrosine peptides from the combining site of a rabbit anti-p-azobenzoate antibody. Eur J Immunol (1976) 0.75
[Apropos of the relation of memory and intelligence in Korsakoff's syndrome]. Ann Med Psychol (Paris) (1969) 0.75